Biocept also appointed Edward Dennis as a director. The company announced the resignation of its former CEO, president and director, Gordon Janko.
Dr Coutts has 30 years of experience in the pharmaceutical and biotechnical industries. He was most recently director of pharmaceutical development at Cypress Bioscience and a principal at Alembic Biotech Consultants. He was previously president and COO at Triad Therapeutics and spent 11 years as executive vice president for R&D at La Jolla Pharmaceutical.
Dr Dennis is currently editor-in-chief of the Journal of Lipid Research and has been named a Fellow of the American Association for the Advancement of Sciences. Dr Dennis serves on the scientific advisory board and board of directors of several private and public companies.
Claire Reiss, chairman of the board, said: “We are pleased to welcome Dr Coutts, a highly regarded professional in our field, and believe he is a good fit with our development strategy. In addition, we are honored to add Dr Dennis to the board and look forward to benefiting from his extensive experience and perspective.”